Stock Market news at lse.co.uk - RSS News Feeds

Reckitt Benckiser Share News (RB.)



Share News for Reckitt Benckiser (RB.)


Share Price: 4,869.00Bid: 4,875.00Ask: 4,877.00Change: 0.00 (0.00%)No Movement on Reckitt Ben. Gp
Spread: 2.00Spread as %: 0.04%Open: 4,885.00High: 4,921.00Low: 4,840.00Yesterday’s Close: 4,869.00




UPDATE 3-Reckitt beats Q3 forecast, raises sales target

Mon, 27th Oct 2008 17:14

LONDON, Oct 27 (Reuters) - British household cleaning products group Reckitt Benckiser beat fo
recasts with a 31 percent rise in third-quarter net profits on Monday and raised its 2008 sales forecast shrugging off fears of a slowdown.

The maker of Cillit Bang cleaner, Airwick air fresheners, and Nurofen painkillers said it expected to see good growth in the fourth-quarter to put it on target for its second-best annual sales growth since the company was formed in 1999.

Chief Executive Bart Becht forecast underlying sales growth would slow to 6-7 percent in the October-December quarter, but still match its increased annual target of 9 percent after achieving 10 percent growth in the first nine-months of 2008.

'Underlying growth in the fourth-quarter of 6 to 7 percent is good in current market conditions, and will be twice as fast as the market, which is growing at around 3 percent,' he added.

Reckitt shares reversed early losses of nearly 5 percent to gain as much as 6.6 percent to 27.70 pounds after the midday results, but its already highly rated shares closed off 0.8 percent at 25.77 pounds in line with a lower London market.

Analyst Charlie Mills at brokers Credit Suisse said it was 'another consensus-beating set of results from Reckitt,' with 'no sign of any slowdown in emerging markets, and continuing strength in the developed world'.

While UBS's Eva Quiroga said, 'Reckitt remains our top-pick in the European home and personal care space, given its superior like-for-like growth, margins and cashflow.'

The group surprised investors by raising its 2008 target for overall revenue growth to 13 percent from at least 11 percent to 12 percent previously after the strong third-quarter, while it held its 11 percent net profit growth goal for 2008, both targets being at constant exchange rates.

For the first nine-months of 2008, the maker of Lysol disinfectants and Finish dishwasher products showed sales and net profits both up 12 percent at constant exchange rates, putting it in line to meet its targets for the full year.

Its underlying 2008 sales growth target was also raised to 9 percent from a previous 7-8 percent reflecting what Becht called the 'better momentum in the underlying business'.

The company posted adjusted net profits for the three months to end-September of 285 million pounds ($440 million), ahead of forecasts of 259 million pounds to 268 million pounds and a consensus of 263 million pounds.

Becht said the performance was led by the 10-percent growth in underlying sales in third-quarter and also the first nine months of the year, driven by new products such as Finish Quantum and Vanish Intelligence and the success of its top 17 powerbrands which also include Dettol, Harpic and Strepsils.

However, in the third-quarter, Reckitt relied on Eastern Europe and other emerging markets for growth, as it saw no growth in Western Europe and North America.

Reckitt shares have shown their defensive qualities this year by outperforming the FTSE 100 index by 46 percent since the start of the year and the DJ European Food and Beverage Index by 12 percent.

(Reporting by David Jones; Editing by Sharon Lindores) ($1=.6480 Pound) Keywords: RECKITT

tf.TFN-Europe_newsdesk@thomsonreuters.com

jlw

COPYRIGHT
Copyright Thomson Financial News Limited 2008. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.


Related Shares: Reckitt Benckiser Gr (RB.) 





MARKET PULSE-Merck, Titan Pharma, Neutral Tandem, Synacor, Brightcove

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49sfaq23t; for the Morning
[1 May '13]

UPDATE 2-FDA rejects Titan drug for opioid dependence

* FDA asks for more data on Probuphine* Titan shares fall 72 percent in early trading* Titan says extremely surprised and disappointed by rulingBy Ton
[1 May '13]

UPDATE 1-Severe U.S. flu season helps Reckitt top forecasts

* Q1 revenues 2.52 bln stg vs forecast 2.47 bln* Growth driven by U.S. flu season, Dettol and Lysol sales* Pharma business up 19 pct, ahead of forecas
[22 Apr '13]

Reckitt benefits from flu season to begin 2013 strongly

LONDON, April 22 (Reuters) - Reckitt Benckiser reported a strong start to 2013 as the maker of Strepsils lozenges and Mucinex decongestant continued
[22 Apr '13]

UPDATE 4-Germany's JAB to buy Douwe Egberts firm in $9.8 bln deal

* Joh A Benckiser agrees to buy D.E Master Blenders* 12.5 euros per share cash bid is below initial proposal* No plans to sell Reckitt shares to fund
[12 Apr '13]

Two U.S. nutrition companies looking for buyers -sources

By Martinne Geller and Olivia OranNEW YORK, April 5 (Reuters) - Santa Cruz Nutritionals and Nellson Nutraceutical LLC are looking for buyers as the la
[5 Apr '13]

STOCKS NEWS EUROPE-D.E Master Blenders surges on takeover talks

D.E Master Blenders surges more than 26 percent to lead FTSEurofirst 300 gainers in heavy volume on news of takeover talks with a German investor that
[28 Mar '13]

STOCKS NEWS EUROPE-Citi adds Reckitt to focus list, drops Danone

Reckitt Benckiser ascends to Citi's European focus list, replacing Danone, with the bank seeing the consumer health company receiving revenue upgrades
[21 Mar '13]



Sign up for Live Prices





Datafeed and UK data supplied by NETbuilder and Interactive Data. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.